Mitigation of hematologic radiation toxicity in mice through pharmacological quiescence induced by CDK4/6 inhibition.
暂无分享,去创建一个
Kwok-Kin Wong | N. Sharpless | Daohong Zhou | C. Torrice | M. R. Ramsey | L. Su | Jian Jin | Soren M Johnson | Q. Jiang | Yong Wang | J. Bell | K. B. Monahan | S. Johnson | Kwok-kin Wong | Kimberly B. Monahan | Qi Jiang | Soren M. Johnson
[1] P. Mosesso,et al. Relationship between chromatin structure, DNA damage and repair following X-irradiation of human lymphocytes. , 2010, Mutation research.
[2] S. Kenney,et al. Hsp90 inhibitors: a potential treatment for latent EBV infection? , 2010, Cell cycle.
[3] D. Hunting,et al. DNA interstrand cross-links induced by ionizing radiation: an unsung lesion. , 2010, Mutation research.
[4] Xiaofeng Jiang,et al. Tip60: Connecting chromatin to DNA damage signaling , 2010, Cell cycle.
[5] L. Meijer,et al. Cyclin-dependent kinase inhibitors: a survey of recent patent literature , 2010, Expert opinion on therapeutic patents.
[6] W. Herr,et al. E2F1 mediates DNA damage and apoptosis through HCF‐1 and the MLL family of histone methyltransferases , 2009, The EMBO journal.
[7] J. Parvin,et al. Cdk1 participates in BRCA1-dependent S phase checkpoint control in response to DNA damage. , 2009, Molecular cell.
[8] Stephen P. Jackson,et al. Human CtIP Mediates Cell Cycle Control of DNA End Resection and Double Strand Break Repair*S⃞ , 2009, Journal of Biological Chemistry.
[9] J. Weiss,et al. History and development of radiation-protective agents , 2009, International journal of radiation biology.
[10] S. Marinopoulos,et al. Treatment of Growing Teratoma Syndrome , 2009 .
[11] Keith W. Caldecott,et al. Single-strand break repair and genetic disease , 2008, Nature Reviews Genetics.
[12] Joseph A. DiDonato,et al. An Agonist of Toll-Like Receptor 5 Has Radioprotective Activity in Mouse and Primate Models , 2008, Science.
[13] Shenghui He,et al. Haematopoietic stem cells do not asymmetrically segregate chromosomes or retain BrdU , 2007, Nature.
[14] Jian Wang,et al. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy. , 2007, Journal of the National Cancer Institute.
[15] K. Wilner,et al. A phase I dose escalation trial of a daily oral CDK 4/6 inhibitor PD-0332991 , 2007 .
[16] D. Carrasco,et al. Expression of p16Ink4a compensates for p18Ink4c loss in cyclin-dependent kinase 4/6-dependent tumors and tissues. , 2007, Cancer research.
[17] N. Sharpless,et al. Lack of extracellular signal-regulated kinase mitogen-activated protein kinase signaling shows a new type of melanoma. , 2007, Cancer research.
[18] P. Fenaux,et al. Anthracyclines, mitoxantrone, radiotherapy, and granulocyte colony-stimulating factor: risk factors for leukemia and myelodysplastic syndrome after breast cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] Nader Fotouhi,et al. Discovery of [4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](2,3-difluoro-6- methoxyphenyl)methanone (R547), a potent and selective cyclin-dependent kinase inhibitor with significant in vivo antitumor activity. , 2006, Journal of medicinal chemistry.
[20] Kum Kum Khanna,et al. Cyclin-dependent kinase 2 functions in normal DNA repair and is a therapeutic target in BRCA1-deficient cancers. , 2006, Cancer research.
[21] G. Shapiro,et al. Cyclin-dependent kinase pathways as targets for cancer treatment. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] P. Olive,et al. The comet assay: a method to measure DNA damage in individual cells , 2006, Nature Protocols.
[23] J. Haveman,et al. Clonogenic assay of cells in vitro , 2006, Nature Protocols.
[24] Irving L. Weissman,et al. Global analysis of proliferation and cell cycle gene expression in the regulation of hematopoietic stem and progenitor cell fates , 2005, The Journal of experimental medicine.
[25] S. Morrison,et al. Supplemental Experimental Procedures , 2022 .
[26] D. W. Fry,et al. Discovery of a potent and selective inhibitor of cyclin-dependent kinase 4/6. , 2005, Journal of medicinal chemistry.
[27] M. Malumbres,et al. Revisiting the “Cdk-Centric” View of the Mammalian Cell Cycle , 2005, Cell cycle.
[28] G. Enders,et al. Cdk inhibition in human cells compromises chk1 function and activates a DNA damage response. , 2005, Cancer research.
[29] James M. Roberts,et al. Living with or without cyclins and cyclin-dependent kinases. , 2004, Genes & development.
[30] N. Pryer,et al. Specific inhibition of cyclin-dependent kinase 4/6 by PD 0332991 and associated antitumor activity in human tumor xenografts. , 2004, Molecular cancer therapeutics.
[31] K. Akashi,et al. Mouse Development and Cell Proliferation in the Absence of D-Cyclins , 2004, Cell.
[32] Pierre Dubus,et al. Mammalian Cells Cycle without the D-Type Cyclin-Dependent Kinases Cdk4 and Cdk6 , 2004, Cell.
[33] Daohong Zhou,et al. Ionizing radiation and busulfan induce premature senescence in murine bone marrow hematopoietic cells. , 2003, Cancer research.
[34] Huichen Wang,et al. DNA damage checkpoint control in cells exposed to ionizing radiation , 2003, Oncogene.
[35] L. Chin,et al. Both products of the mouse Ink4a/Arf locus suppress melanoma formation in vivo , 2003, Oncogene.
[36] S. A. Watkins,et al. Synthesis, structure-activity relationship, and biological studies of indolocarbazoles as potent cyclin D1-CDK4 inhibitors. , 2003, Journal of medicinal chemistry.
[37] P. Bourin,et al. Short-term injection of antiapoptotic cytokine combinations soon after lethal gamma -irradiation promotes survival. , 2003, Blood.
[38] I. Weissman,et al. Myeloerythroid-restricted progenitors are sufficient to confer radioprotection and provide the majority of day 8 CFU-S. , 2002, The Journal of clinical investigation.
[39] Mikhail V. Blagosklonny,et al. The Restriction Point of the Cell Cycle , 2002, Cell cycle.
[40] D. Lawrence,et al. Protection of normal proliferating cells against chemotherapy by staurosporine-mediated, selective, and reversible G(1) arrest. , 2000, Journal of the National Cancer Institute.
[41] D. Scadden,et al. Hematopoietic stem cell quiescence maintained by p21cip1/waf1. , 2000, Science.
[42] P. Leder,et al. Loss of p21 increases sensitivity to ionizing radiation and delays the onset of lymphoma in atm-deficient mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[43] L. Chin,et al. Cooperative effects of INK4a and ras in melanoma susceptibility in vivo. , 1997, Genes & development.
[44] K. Helin,et al. Induction of DNA synthesis and apoptosis are separable functions of E2F-1. , 1997, Genes & development.
[45] L Meijer,et al. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. , 1997, European journal of biochemistry.
[46] G. Wahl,et al. DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. , 1994, Genes & development.
[47] Stephen J. Elledge,et al. p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest , 1994, Cell.
[48] David Beach,et al. p21 is a universal inhibitor of cyclin kinases , 1993, Nature.
[49] E. Sausville,et al. Growth inhibition with reversible cell cycle arrest of carcinoma cells by flavone L86-8275. , 1992, Journal of the National Cancer Institute.
[50] M. Wick,et al. In vivo radioprotective effects of recombinant human granulocyte colony-stimulating factor in lethally irradiated mice. , 1990, Blood.
[51] G. Kraft,et al. The formation of radiation-induced DNA breaks: the ratio of double-strand breaks to single-strand breaks. , 1985, International journal of radiation oncology, biology, physics.
[52] M. Nüsse,et al. The importance of G1/S-border and mitosis in the fixation of potentially lethal damage , 1983, Radiation and environmental biophysics.
[53] A. Pardee,et al. A restriction point for control of normal animal cell proliferation. , 1974, Proceedings of the National Academy of Sciences of the United States of America.
[54] J. Little. Repair of Sub-lethal and Potentially Lethal Radiation Damage in Plateau Phase Cultures of Human Cells , 1969, Nature.
[55] M. Elkind,et al. Radiation response of mammalian cells grown in culture. VI. Protein, DNA, and RNA inhibition during the repair of x-ray damage. , 1967, Radiation research.
[56] W. K. Sinclair,et al. X-ray sensitivity during the cell generation cycle of cultured Chinese hamster cells. , 1966, Radiation research.
[57] L. Tolmach,et al. X-Ray Sensitivity and DNA Synthesis in Synchronous Populations of HeLa Cells , 1963, Science.
[58] M. Elkind,et al. Radiation response of mammalian cells grown in culture: III. Modification of X-ray survival of Chinese hamster cells by 5-bromodeoxyuridine , 1963 .
[59] M. Grenan,et al. Radioprotection by Mitotic Inhibitors and Mercaptoethylamine , 1961, Science.
[60] H. Sutton,et al. Radiation response of mammalian cells grown in culture. 1. Repair of X-ray damage in surviving Chinese hamster cells. , 1960, Radiation research.
[61] M. M. ELKIND,et al. X-Ray Damage and Recovery in Mammalian Cells in Culture , 1959, Nature.
[62] W. W. Smith. Protective effect of a colchicine derivative in mice exposed to x-radiation. , 1958, Science.